Tom Monroe

Tom is a retired biotech executive. Most recently, he was a founder and the CEO of Vaxxilon (Berlin and Basel), a company developing prophylactic vaccines to target anti-microbial resistant pathogens. Prior to Vaxxilon, he worked for Actelion in Basel, Sydney, Shanghai, and San Francisco in a variety of roles including starting subsidiaries in several locations. He also worked for Roche, Syntex, Piedmont Clinical Labs, and Economic Analysis Corporation.

Tom earned a BA from Pomona College (Economics, International Relations) and an MS from the Massachusetts Institute of Technology (Management – Finance and Operations).